Literature DB >> 16937266

Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells.

Mitsuru Yagi1, Takeshi Miyamoto, Yoshiaki Toyama, Toshio Suda.   

Abstract

Osteoclasts are the only cells that can resorb bone matrix physiologically and maintain the bone content. Osteoclasts are derived from macrophage/monocyte lineage cells; stimulation by macrophage colony stimulating factor and receptor activator of NFkappaB ligand induces osteoclastogenesis. During osteoclastogenesis, preosteoclasts fuse to form multinuclear mature osteoclasts. Cellular fusion is a unique phenomenon and enables fertilization, myotube formation, and efficient bone resorption in vertebrates. To date, several molecules have been reported to be fusion related in osteoclasts, namely CD44, CD47, ADAM12, MCP-1, and CD9, although the molecules which regulate osteoclast cellular fusion remain unclear. Here, we show that the seven-transmembrane-region receptor dendritic cell-specific transmembrane protein (DC-STAMP) is required for cell-cell fusion of osteoclasts and foreign body giant cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937266     DOI: 10.1007/s00774-006-0697-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  19 in total

1.  ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.

Authors:  Pierre Guermonprez; Loredana Saveanu; Monique Kleijmeer; Jean Davoust; Peter Van Endert; Sebastian Amigorena
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

2.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

3.  DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells.

Authors:  F C Hartgers; J L Vissers; M W Looman; C van Zoelen; C Huffine; C G Figdor; G J Adema
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

4.  CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation.

Authors:  X Han; H Sterling; Y Chen; C Saginario; E J Brown; W A Frazier; F P Lindberg; A Vignery
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

5.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.

Authors:  H Yoshida; S Hayashi; T Kunisada; M Ogawa; S Nishikawa; H Okamura; T Sudo; L D Shultz; S Nishikawa
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  Bifurcation of osteoclasts and dendritic cells from common progenitors.

Authors:  T Miyamoto; O Ohneda; F Arai; K Iwamoto; S Okada; K Takagi; D M Anderson; T Suda
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

7.  Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos.

Authors:  Koichi Matsuo; Deborah L Galson; Chen Zhao; Lan Peng; Catherine Laplace; Kent Z Q Wang; Marcus A Bachler; Hitoshi Amano; Hiroyuki Aburatani; Hiromichi Ishikawa; Erwin F Wagner
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

8.  MFR, a putative receptor mediating the fusion of macrophages.

Authors:  C Saginario; H Sterling; C Beckers; R Kobayashi; M Solimena; E Ullu; A Vignery
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

9.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

10.  RANKL-induced DC-STAMP is essential for osteoclastogenesis.

Authors:  Toshio Kukita; Naohisa Wada; Akiko Kukita; Takashi Kakimoto; Ferry Sandra; Kazuko Toh; Kengo Nagata; Tadahiko Iijima; Madoka Horiuchi; Hiromi Matsusaki; Kunio Hieshima; Osamu Yoshie; Hisayuki Nomiyama
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

View more
  48 in total

1.  Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells.

Authors:  James R Sissons; Jacques J Peschon; Frank Schmitz; Rosa Suen; Mark Gilchrist; Alan Aderem
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Vitamin E: good for the heart, bad for the bones?

Authors:  G David Roodman
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

Review 3.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

5.  A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and inflammatory bone destruction.

Authors:  Yanhui Tan; Wende Deng; Yueyang Zhang; Minhong Ke; Binhua Zou; Xiaowei Luo; Jianbin Su; Yiyuan Wang; Jialan Xu; Kutty Selva Nandakumar; Yonghong Liu; Xuefeng Zhou; Xiaojuan Li
Journal:  Br J Pharmacol       Date:  2020-08-11       Impact factor: 8.739

6.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

7.  Enoxacin directly inhibits osteoclastogenesis without inducing apoptosis.

Authors:  Edgardo J Toro; Jian Zuo; David A Ostrov; Dana Catalfamo; Vivian Bradaschia-Correa; Victor Arana-Chavez; Aliana R Caridad; John K Neubert; Thomas J Wronski; Shannon M Wallet; L Shannon Holliday
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

8.  Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Ya-Hui Chiu; Kofi A Mensah; Edward M Schwarz; Yawen Ju; Masahiko Takahata; Changyong Feng; Loralee A McMahon; David G Hicks; Ben Panepento; Peter C Keng; Christopher T Ritchlin
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

9.  Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions.

Authors:  Akihito Oya; Eri Katsuyama; Mayu Morita; Yuiko Sato; Tami Kobayashi; Kana Miyamoto; Toru Nishiwaki; Atsushi Funayama; Yoshinari Fujita; Takashi Kobayashi; Morio Matsumoto; Masaya Nakamura; Arihiko Kanaji; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2017-12-22       Impact factor: 2.626

Review 10.  The emerging field of osteoimmunology.

Authors:  Kofi A Mensah; Jie Li; Edward M Schwarz
Journal:  Immunol Res       Date:  2009-01-30       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.